Failure of recombinant stem cell factor to enhance engraftment of L-leucyl-L-leucine methyl ester treated canine marrow after irradiation

Blood. 1996 Sep 1;88(5):1896-7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Bone Marrow / drug effects
  • Bone Marrow / pathology
  • Bone Marrow Purging / methods*
  • Bone Marrow Transplantation*
  • Dipeptides / pharmacology
  • Dipeptides / therapeutic use*
  • Dogs
  • Graft Survival / drug effects*
  • Graft vs Host Disease / prevention & control*
  • Hematopoietic Stem Cells / drug effects
  • Hematopoietic Stem Cells / pathology
  • Histocompatibility Antigens Class I / immunology
  • Mice
  • Radiation Chimera
  • Recombinant Proteins / pharmacology
  • Recombinant Proteins / therapeutic use
  • Species Specificity
  • Stem Cell Factor / pharmacology
  • Stem Cell Factor / therapeutic use*
  • T-Lymphocytes, Cytotoxic / drug effects
  • Treatment Failure

Substances

  • Dipeptides
  • Histocompatibility Antigens Class I
  • Recombinant Proteins
  • Stem Cell Factor
  • histocompatibility antigen DLA
  • leucyl-leucine-methyl ester